Lipid Excipient Development

Which Custom Lipid Excipients Can We Develop for Your Drug?

At BOC Sciences, we have extensive experience in lipid excipient development and application, enabling us to tailor optimal solutions for different drug molecules. Whether enhancing solubility of hydrophobic drugs, achieving controlled release, or optimizing oral or injectable bioavailability, we provide validated lipid excipient combinations and application strategies to ensure efficient project progression while meeting process and clinical requirements.

Integrated Lipid Excipient Development for Your Formulation Needs

With advanced lipid screening technology and professional formulation design capabilities, we provide optimal lipid excipient solutions for a wide range of drug molecules. Our team is proficient in the development of nanoemulsions, liposomes, solid lipid nanoparticles (SLN/NLC), and microemulsion formulations, enabling precise control over drug release, enhanced solubility, and improved bioavailability.

Lipid Screening Services

• High-throughput lipid screening services to rapidly match the most suitable excipients based on drug hydrophobicity, molecular weight, and chemical properties.
• Analyze lipid-drug compatibility and solubilization capacity to ensure drug loading efficiency and formulation stability.
• Screen both natural and synthetic lipids, including glycerides, phospholipids, glycolipids, and functional surfactant lipids, covering a broad range of applications.
• Recommend the optimal lipid combinations based on administration route and targeting requirements, laying a solid foundation for formulation design.

Formulation Design Services

• Customized formulation design, integrating lipid excipients with drug properties to enhance solubility, achieve controlled release, or enable targeted delivery.
• Optimize emulsion systems, microemulsions, nanoemulsions, or liposome structures to ensure formulation stability and manufacturability.
• Use computational modeling and experimental validation to predict lipid-drug interactions and improve R&D efficiency.
• Provide multiple dosage form design options, including oral, injectable, topical, and nucleic acid delivery formulations.

Formulation Development Services

• Laboratory-scale formulation development to optimize lipid excipient ratios, particle size, and drug loading.
• Test physicochemical properties, drug release behavior, and bioavailability metrics.
• Develop various formulation types, including nanolipid particles, solid lipid nanoparticles (SLN/NLC), liposomes, microemulsions, and emulsions.
• Support the development of functionalized lipids for targeted delivery, controlled release, and biocompatibility optimization.

Process Optimization Services

• Optimize processes such as high-pressure homogenization, ultrasonic emulsification, spray drying, and hot-melt preparation to ensure scalability.
• Adjust critical process parameters to control particle size, drug encapsulation, and release characteristics.
• Conduct reproducibility assessments to guarantee smooth scale-up from laboratory to pilot scale.
• Integrate quality control and process monitoring technologies to optimize formulation stability and batch consistency.

Quality Verification Services

• Comprehensive quality verification of formulations and processes, including drug content, particle size, encapsulation efficiency, and stability assessment.
• Provide regulatory-compliant technical reports and validation data to support IND or clinical research needs.
• Evaluate key lipid excipients for safety, purity, and in vivo compatibility.
• Deliver end-to-end documentation support to ensure projects are traceable, compliant, and efficient.

The Advantages of Working with Our Lipid Excipient Experts

• Customized Development: We design tailored lipid excipient solutions based on each client's drug characteristics, route of administration, and development objectives, ensuring optimal performance in terms of solubility, stability, and clinical applicability.
• High-Throughput Lipid Screening: Using advanced high-throughput screening platforms, we rapidly identify optimal lipid combinations and precisely match excipients to different drug molecules, significantly improving development efficiency and success rates.
• Laboratory Development and Process Optimization: We provide end-to-end development and optimization from laboratory research to small-scale processes, precisely controlling particle size, drug release, and stability to ensure formulations are scalable to cGMP manufacturing.
• Comprehensive Quality and Regulatory Support: All developed lipid excipients meet pharmaceutical-grade and cGMP standards, supporting IND, NDA, and clinical trial submissions while ensuring the highest levels of safety, stability, and regulatory compliance.
• Expert Technical Team: Our multidisciplinary team of biochemistry, pharmaceutical formulation, and nanotechnology experts delivers full technical support—from lipid selection and formulation design to cGMP-grade formulation development—addressing complex R&D challenges.
• One-Stop Service Capability: We offer a complete workflow covering lipid screening, formulation design, formulation development, process optimization, and cGMP quality verification, enabling rapid delivery and shortened development timelines with reliable outcomes.
• Advanced Facilities and Efficient Support: Equipped with modern laboratories and cGMP-compliant manufacturing facilities, combined with optimized workflows and technology platforms, we provide reliable, high-quality, and scalable lipid excipient development and validation support.

How We Develop Custom Lipid Excipients for Your Drug?

BOC Sciences follows a rigorous and systematic lipid excipient development workflow, covering drug analysis, process optimization, and regulatory support. This ensures efficiency, reliability, and meets clients' R&D requirements at different stages. Our goal is to provide scalable, stable, and pharmaceutical-grade lipid excipient solutions through systematic development.

Project Consultation & Analysis

• Professional lipid excipient consultation to evaluate drug properties and excipient selection strategies.
• Provide preliminary feasibility analysis to reduce development risk and cost.
• Assist clients in planning timelines and technical routes for efficient project progression.
• Share experience and provide expert guidance to support fast project initiation and informed decision-making.

Drug Property Analysis

• Comprehensive analysis of drug molecules, including molecular weight, hydrophobicity, solubility, and stability, to inform lipid selection.
• Consider administration routes (oral, injectable, topical, or nucleic acid delivery) and therapeutic goals to guide formulation direction.
• Evaluate compatibility with different lipids and predict interactions to ensure feasibility.
• Identify metabolic features and release requirements for subsequent formulation design.

Lipid Screening & Formulation Design

• High-throughput screening of glycerides, phospholipids, glycolipids, and functional surfactant lipids to determine optimal excipient systems.
• Design preliminary formulations (emulsions, microemulsions, nanoemulsions, liposomes, or solid lipid particles) based on drug properties.
• Assess the impact of different lipid combinations on solubility, loading efficiency, stability, and release characteristics.
• Provide comparative analysis to balance performance and manufacturability.

Laboratory-Scale Formulation Development

• Optimize formulations at lab scale, controlling particle size, encapsulation efficiency, and physicochemical stability.
• Test drug release profiles and in vitro performance to meet design goals.
• Conduct preliminary safety and toxicity evaluations for materials and formulations.
• Iteratively optimize formulations to provide reliable data for process scale-up.

Process Optimization, Scale-Up & Quality Verification

• Optimize high-pressure homogenization, ultrasonic emulsification, spray drying, and hot-melt processes for reproducibility and scalability.
• Adjust key parameters to control particle size, drug release, and encapsulation efficiency for optimal stability.
• Conduct small-scale scale-up validation and verify quality attributes including drug content, particle size, encapsulation, and release.
• Provide complete technical documentation and development reports to ensure pharmaceutical-grade standards, supporting clinical and commercial applications.

Client Customization & End-to-End Technical Support

• Deliver personalized lipid excipient solutions tailored to drug properties and formulation requirements.
• Provide full technical support from early-stage development to pilot and small-scale production, accelerating R&D timelines and optimizing efficiency.
• Interpret experimental data, analyze issues, and offer optimization recommendations to ensure reliable decision-making.
• Collaborate closely with clients to maintain transparency, traceability, and meet clinical and commercial application needs.

Lipid Excipient Applications Across Drug Delivery Systems

Lipid excipients play a key role in modern drug formulations and advanced delivery systems, improving solubility, bioavailability, and enabling controlled release and targeted delivery.

Liposome Formulations

Lipid excipients form the core of liposomes by constructing phospholipid bilayers to encapsulate small molecules, proteins, or nucleic acids. Liposomes enable controlled release, extended circulation, and targeted delivery via surface modification, reducing side effects. Representative examples include Doxil® and other targeted anticancer drugs.

Nanoemulsions & Microemulsions

Lipid excipients can create stable nano- or microemulsion systems for oral, injectable, or topical administration. These systems enhance solubility and bioavailability of hydrophobic drugs while maintaining in vivo stability. Proper ratio optimization and process control enable scalable production and adjustable drug release rates.

Solid Lipid Nanoparticles (SLN) & Nanostructured Lipid Carriers (NLC)

SLN and NLC utilize combinations of solid and liquid lipids to achieve controlled drug release and improved in vivo stability. Surface modification allows targeting specific tissues or cells for precise delivery. These systems are widely used for anticancer, anti-infective drugs, and vaccine carriers.

Nucleic Acid & Gene Delivery

Cationic lipid excipients are critical for delivering mRNA, siRNA, and DNA. Ionizable lipids in LNPs enhance cellular uptake and release efficiency. Lipid excipients regulate particle stability, encapsulation, and in vivo distribution to ensure safe and effective therapeutic action.

Oral Lipid Formulations

Widely used in oil-filled capsules, emulsions, and solid dispersions, lipid excipients improve solubility and absorption of poorly soluble drugs. By adjusting lipid ratios and particle structures, they can provide controlled or rapid release, enhancing oral bioavailability while maintaining stability and manufacturability.

Topical & Localized Formulations

Lipid excipients serve as emulsifiers, penetration enhancers, and controlled-release agents in transdermal patches, ointments, creams, and topical emulsions. They improve drug penetration through skin or mucosa, enhance local efficacy, and reduce systemic side effects, providing effective and controllable delivery for dermatological, anti-inflammatory, and analgesic therapies.

Frequently Asked Questions

Still have questions?

Contact Us

• What is Lipid-Based Excipients?

  Lipid excipients are an important component of drug delivery systems, providing multiple functions such as solubilization, stabilization, and controlled release of active pharmaceutical ingredients (APIs). Lipid-based drug delivery systems can improve the solubility, bioavailability, and stability of APIs, thereby improving therapeutic efficacy. Lipid excipients can be used to formulate various types of drug delivery systems, including lipid nanoparticles, liposomes, emulsions, and solid lipid nanoparticles. These systems can be designed to deliver drugs through different routes of administration (e.g., oral, parenteral, and topical).

• What are the excipients in lipid nanoparticles?

  Excipients in lipid nanoparticles include surfactants, stabilizers, and co-solvents. Some common excipients used in lipid nanoparticles include phospholipids, cholesterol, polyethylene glycol (PEG), and other nonionic surfactants. These excipients help stabilize lipid nanoparticles, improve their drug-loading capacity and control their release profile.

• What are lipid based drugs examples?

  Lipid pharmaceutical system refers to a type of pharmaceutical preparation in which one or more API are encapsulated in a lipid bilayer or/and in an aqueous phase to form a drug-loaded system. Currently, approved drugs based on lipid formulations include Amprenavir, Ranitidine, Topotecan, Sirolimus, Saquinavir, Tipranavir, Dutasteride, and Cyclosporine.

• What types of lipid excipients do you develop?

  We develop a wide range of lipid excipients, including glycerides, phospholipids, sugar-based lipids, and functional surfactants. Our team selects lipids based on drug properties and formulation goals, ensuring compatibility, stability, and optimal performance. These excipients can be tailored for oral, injectable, topical, or gene delivery applications, supporting diverse drug types from small molecules to nucleic acids and biologics.

• How do you support formulation development?

  We provide end-to-end formulation support, from initial lipid screening to small-scale lab development and process optimization. Our team optimizes lipid combinations, drug loading, particle size, and release characteristics to meet stability and performance goals. All formulations are designed for scalability, ensuring seamless transition from research to clinical or commercial production.

• Can you help improve poorly soluble drugs?

  Yes. We specialize in enhancing solubility and bioavailability of poorly soluble compounds using lipid-based systems such as nanoemulsions, solid lipid nanoparticles, and self-emulsifying formulations. By selecting optimal lipids and designing tailored delivery systems, we improve dissolution, absorption, and stability, helping clients overcome solubility challenges and accelerate development timelines.

• How do you support lipid-based gene and nucleic acid delivery?

  We develop cationic and ionizable lipid excipients for mRNA, siRNA, and DNA delivery systems, including lipid nanoparticles (LNPs). Our excipients optimize nucleic acid encapsulation, cellular uptake, and endosomal release while maintaining stability and safety. We support design, screening, and small-scale development to accelerate preclinical and clinical research in gene therapy and mRNA vaccine applications.

Case Studies and Success Stories

Publications

This section showcases academic publications from international research teams using BOC Sciences' products and services, highlighting our industry impact in lipid supply and R&D.

• An advanced TALSPEAK concept for separating minor actinides. Part 2. Flowsheet test with actinide-spiked simulant. Solvent Extraction and Ion Exchange 35.6 (2017): 396-407. DOI: 10.1080/07366299.2017.1368945.
• Development and validation of rapid and simultaneous method for determination of 12 hair-growth compounds in adulterated products by UHPLC–MS/MS. Forensic science international 284 (2018): 129-135. PMID: 29408720 DOI: 10.1016/j.forsciint.2017.12.042.
• Cuban Policosanol (Raydel®) Exerts Higher Antioxidant and Anti-Glycation Activities than Chinese Policosanol (BOC Sciences) in Reconstituted High-Density Lipoproteins: In Vivo Anti-Inflammatory Activities in Zebrafish and Its Embryos. Pharmaceuticals 17.4 (2024): 406. DOI: 10.3390/ph17040406.
• Hopanoids, like sterols, modulate dynamics, compaction, phase segregation and permeability of membranes. Biochimica et Biophysica Acta (BBA)-Biomembranes (2019): 183060. DOI: 10.1016/j.bbamem.2019.183060.
• The long-chain monounsaturated cetoleic acid improves the efficiency of the n-3 fatty acid metabolic pathway in Atlantic salmon and human HepG2 cells. Br J Nutr. 2019; 122(7): 755-768. DOI: 10.1017/S0007114519001478.

Client Testimonials

Industry Distribution of Custom Lipid Synthesis Clients

"Developing a lipid-based oral formulation for a poorly soluble drug was challenging. BOC Sciences provided tailored excipient solutions, optimized our formulation, and delivered detailed technical reports. Their expertise significantly accelerated our preclinical studies."

— Dr. James Carter, Formulation Scientist (USA)

"BOC Sciences helped us identify the optimal lipid excipient for a new mRNA delivery system. Their high-throughput screening and lab-scale development were invaluable. The resulting LNP formulation met all our stability and encapsulation targets."

— Prof. Emily Johansson, Senior Researcher (Sweden)

"We needed a scalable lipid nanoparticle system for a nucleic acid therapeutic. BOC Sciences guided us through excipient selection, formulation design, and small-scale optimization. The service was professional, and the technical support was exceptional."

— Mr. Oliver Smith, Drug Delivery Specialist (UK)

"Facing solubility challenges with a novel anti-inflammatory compound, BOC Sciences developed a nanoemulsion system that significantly improved bioavailability. The team's scientific approach and attention to detail gave us confidence in advancing the project."

— Dr. Claire Müller, R&D Scientist (Germany)

"BOC Sciences supported us with the development of solid lipid nanoparticles for a lipophilic drug. Their expertise in lipid excipients and formulation optimization ensured the process was reproducible and scalable. The project was delivered on time with thorough documentation."

— Mr. Lucas Thompson, Pharmaceutical Development Manager (Canada)

"We required a custom lipid excipient for a topical drug formulation. BOC Sciences provided multiple design options, technical guidance, and regulatory-compliant documentation. Their collaborative approach and scientific rigor made them a trusted partner throughout the project."

— Dr. Sophie Dubois, Formulation Lead (France)